1
Study of Recombinant Factor IX Product, IB1001, in Previously Treated Subjects With Hemophilia B
Condition(s):Hemophilia BLast Updated:August 23, 2016Withdrawn
Hide Studies Not Open or Pending
Condition(s):Hemophilia BLast Updated:August 23, 2016Withdrawn
Condition(s):Hepatitis B; Liver TransplantationLast Updated:November 1, 2013Completed
Condition(s):VaricellaLast Updated:April 4, 2013Approved for marketing
Condition(s):Hepatitis BLast Updated:September 28, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.